Avadel Pharmaceuticals plc

Historical 13F Holders

Symbol
AVDL
CUSIP
G29687103
All holders as of
Q1 2026
Type
Equity
Class
COM SHS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for G29687103 since 12/18/2024, newest first.

Filer % of Class Filed
Janus Henderson Group PLC 13G/A Amendment 7 1.9% 2/17/2026
Event 12/31/2025
Two Seas Capital LP 13G/A Amendment 2
0% 2/17/2026
Event 12/31/2025
Brandes Investment Partners, LP 13G/A Amendment 1 0.2% 2/12/2026
Event 12/31/2025
Janus Henderson Group PLC 13G/A Amendment 6 7.7% 11/14/2025
Event 9/30/2025
Janus Henderson Group PLC 13G/A Amendment 5 11.5% 8/14/2025
Event 6/30/2025
Two Seas Capital LP 13G/A Amendment 1
6.4% 8/13/2025
Event 6/30/2025
Vanguard Group Inc 13G 5.7% 7/29/2025
Event 6/30/2025
Vanguard Group Inc 13G 5.7% 7/29/2025
Event 6/30/2025
BlackRock, Inc. 13G/A Amendment 1 7.0% 7/16/2025
Event 6/30/2025
Two Seas Capital LP 13G
5.1% 5/15/2025
Event 3/31/2025
Janus Henderson Group PLC 13G/A Amendment 4
14.1% 5/14/2025
Event 3/31/2025
Brandes Investment Partners, LP 13G 5.9% 5/14/2025
Event 3/31/2025
Janus Henderson Group PLC 13G/A Amendment 3
14.6% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q1 1 20.0 $426.00
2025 Q4 228 73.6 M $1.59 B
2025 Q3 202 79.8 M $1.22 B
2025 Q2 182 81.4 M $720 M
2025 Q1 192 77.3 M $607 M
2024 Q4 179 78.9 M $830 M
2024 Q3 199 73.7 M $967 M
2024 Q2 169 67.9 M $1.28 B
2024 Q1 8 2.17 M $36.6 M
2023 Q1 1 468 $4.29 k